For millions of people in the United States and abroad, kratom—an herbal product derived from the leaves of Mitragyna speciosa, a tropical tree native to Southeast Asia—has become part of health and wellness routines. Some use it for energy, others for calm, and many turn to it for pain relief as an alternative to opioids. But as kratom use has grown, so has another question, particularly among those facing employment or legal screenings: will kratom show up on a drug test?
The answer is not as straightforward as with many other substances. Unlike marijuana, opioids, or amphetamines—commonly tested, federally recognized Schedule I–II controlled substances—kratom does not appear on standard workplace drug panels. However, this does not mean it is undetectable. Under certain testing conditions, kratom can indeed be identified, and detection windows vary depending on biology, frequency of use, and the specific test used.
What Is Kratom and Why Test for It?
Kratom contains active alkaloids, primarily mitragynine and 7-hydroxymitragynine, that act on opioid receptors in the brain. While not federally scheduled in the U.S., the Drug Enforcement Administration (DEA) notes that kratom has opioid-like properties and potential for misuse. The Food and Drug Administration (FDA) has not approved kratom for medical use, citing safety concerns and potential health risks, including dependence.
Because of this, kratom testing is most common in forensic, clinical, and certain workplace contexts where substance use monitoring goes beyond standard 5- or 10-panel drug screens. A 2020 report from the Substance Abuse and Mental Health Services Administration (SAMHSA) highlighted rising concerns around kratom use, prompting some specialized labs to include it in custom toxicology panels.
Standard Drug Panels vs. Specialized Testing
Most workplace drug tests—particularly the U.S. Department of Transportation’s federally mandated 5-panel urine test—screen for marijuana (THC), cocaine, amphetamines, opioids, and phencyclidine (PCP). Kratom alkaloids are not structurally similar to these substances and therefore are not detected by standard tests.
To detect kratom, laboratories must use specialized testing methods such as high-performance liquid chromatography (HPLC) or liquid chromatography-mass spectrometry (LC-MS). These methods specifically target mitragynine and its metabolites.
This distinction matters: while an employer following federal testing guidelines is unlikely to detect kratom use, clinical settings (for example, pain clinics monitoring opioid alternatives) may specifically test for it.
How Long Can Kratom Be Detected?
The detection window for kratom depends on several factors, including metabolism, frequency of use, and the type of test administered. According to Mountain West Wire and other scientific sources, here’s what’s known:
-
Urine Test:
The most common drug testing method. Kratom metabolites can typically be detected in urine for up to 7 days after use, though some users may eliminate it more quickly if they have a fast metabolism or use kratom infrequently. -
Blood Test:
Kratom alkaloids, once ingested, circulate in the bloodstream but are processed relatively quickly. On average, blood tests can detect kratom for about 24 hours following use. Studies show mitragynine has a half-life of roughly 3–9 hours, depending on individual liver metabolism. -
Saliva Test:
Much less common, but when administered, saliva tests can usually detect kratom for 1–2 days after ingestion. Salivary testing is sometimes used in roadside checks or clinical rapid-screen scenarios because of its convenience. -
Hair Test:
The most long-term indicator. Like other substances, kratom metabolites can be trapped in hair shafts through blood circulation. Depending on hair length, kratom may be detectable for up to 90 days or longer, making this method particularly relevant in forensic or legal contexts.
Key Factors That Affect Detection
There is no single timeframe for kratom detection; instead, several biological and external factors play a role:
-
Metabolism Rate: Individuals with faster metabolic rates process kratom more quickly, shortening detection windows. Liver health, age, and overall genetics play a role in this variability.
-
Frequency of Use: Daily or high-dose kratom users accumulate more metabolites, which linger in the system longer than in occasional users.
-
Dosage: Larger doses increase the concentration of kratom alkaloids, extending detectability.
-
Test Sensitivity: Some labs set very low detection thresholds. In cases where high-sensitivity LC-MS screening is used, even small amounts of kratom may trigger a positive result.
-
Hydration and Diet: Drinking fluids and maintaining a quicker metabolic turnover can slightly influence how quickly kratom metabolites leave the system, though not enough to bypass sensitive tests fully.
False Positives and Drug Testing Concerns
One of the common worries among kratom users is whether the substance could cause a false positive for opioids on a workplace drug screen. Current toxicology literature suggests that kratom does not typically trigger false positives on standard tests for opioids, THC, or other substances. According to SAMHSA testing protocols, kratom alkaloids are chemically distinct from illicit opioids and cannabinoids, reducing the likelihood of cross-reactivity.
However, advanced testing specifically looking for mitragynine can confirm recent kratom use.
Why It Matters for Employees and Patients
For individuals in fields requiring strict sobriety—such as transportation, healthcare, or law enforcement—the distinction between kratom being absent from routine tests yet detectable under specialized screenings is critical. Employers or probation officers can request targeted testing if kratom use is suspected.
This becomes even more important given the regulatory uncertainty surrounding kratom. According to the National Conference of State Legislatures, several U.S. states—including Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin—have banned kratom, while others regulate its sale under “Kratom Consumer Protection Acts.”
In states or jobs where kratom use is not permitted, detection could have employment or legal consequences even though it is not federally scheduled.
Detox and Elimination
Unlike alcohol, there is no quick “flush” method to eliminate kratom before a test. Once consumed, kratom must be metabolized and excreted naturally. While hydration, exercise, and nutrition may support metabolism, they cannot drastically alter detection times.
Medical experts emphasize one key point: time is the only reliable factor when it comes to clearing kratom from the body prior to a drug test.
Risks and Health Considerations
While the central concern in drug testing revolves around detection, it would be incomplete to overlook the broader health picture. The FDA and National Institute on Drug Abuse (NIDA) both caution that kratom carries risks. Reported adverse effects include dependence, withdrawal symptoms, nausea, liver toxicity, and in some cases, seizures when combined with other substances.
At the same time, anecdotal surveys and research published in Drug and Alcohol Dependencesuggest some users find kratom helpful for reducing pain, managing opioid withdrawal, or improving mood. The science remains unsettled, and federal regulators continue to monitor its safety profile closely.
Conclusion
So, will kratom show up on a drug test? The short answer is: not usually on standard screenings, but yes on specialized tests. Urine remains the most common method for detection, with possible visibility up to a week, while blood, saliva, and hair tests provide shorter or much longer windows depending on usage patterns.
For workers, patients, and anyone subject to legal probation, understanding these nuances is critical. While kratom is not automatically flagged in routine panels, its metabolites can be tracked if testing is specifically designed for it. And in states with tighter kratom regulations, even a specialized detection could carry consequences.
As kratom’s popularity continues to grow, both its supporters and regulators will watch closely how testing evolves—and how individuals weigh its benefits against legal and professional risks.